---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-196112"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:36:00.341673+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Verrica posts updated corporate presentation; no specific material changes disclosed

## Summary
- Company filed an updated corporate presentation on its website on July 27, 2023.
- Presentation content was not fully provided in the filing; only a title page was available.
- No financial results, guidance, or strategic updates were detailed in the 8-K or exhibit.
- This is a routine Regulation FD disclosure with no new quantitative data for investors.

## SEC filing metadata
- accession: 0001193125-23-196112
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/0001193125-23-196112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/d523492d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-196112
- JSON: https://secwatch.observer/filing/0001193125-23-196112.json
- Plain text: https://secwatch.observer/filing/0001193125-23-196112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.